1. E. R. Squibb Sons, Inc. (29 from 1,624 patents)

2. Zafgen, Inc. (19 from 48 patents)

3. Agios Pharmaceuticals, Inc. (7 from 96 patents)

4. Bristol-myers Squibb Compnay (3 from 3,684 patents)

5. Tetraphase Pharmaceuticals, Inc. (3 from 17 patents)

6. Osi Pharmaceuticals, Inc. (2 from 118 patents)

7. Servier Pharmaceuticals LLC (2 from 21 patents)

8. Advinus Therapeutics Private Limited (2 from 15 patents)

9. Morphic Therapeutic, Inc. (2 from 15 patents)

10. The General Hospital Corporation (1 from 2,893 patents)

11. National University of Singapore (1 from 806 patents)

12. Institut National De La Recherche Scientifique (1 from 123 patents)

13. Piramal Enterprises Limited (1 from 48 patents)

14. Bristol-myers Squibb (1 from 36 patents)

15. Syros Pharmaceuticals, Inc. (24 patents)

1. 12433895 - Therapeutically active compounds and their methods of use

2. 11844758 - Therapeutically active compounds and their methods of use

3. 11370773 - Inhibiting human integrin (alpha-4) (beta-7)

4. 11104661 - Inhibiting human integrin (α-4) (β-7)

5. 10946023 - Therapeutically active compounds and their methods of use

6. 10220015 - Fumigillol compounds and methods of making and using same

7. 10175256 - Compositions and methods utilizing lysophosphatidylcholine scaffolds

8. 10172864 - Therapeutically active compounds and their methods of use

9. 10174009 - Tricyclic sulphonamide compounds and methods of making and using same

10. 10028961 - Therapeutically active compounds and their methods of use

11. 10023561 - Fumagillol heterocyclic compounds and methods of making and using same

12. 9944613 - Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using same

13. 9895339 - Fumigillol compounds and methods of making and using same

14. 9868717 - Tricyclic sulphonamide compounds and methods of making and using same

15. 9839623 - Tricyclic compounds and methods of making and using same